WILMINGTON, Mass. & BERLIN--(BUSINESS WIRE)--Dec. 12, 2023-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into an agreement with CELLphenomics, a service-based biotechnology company that is using 3D…

Berlin, Germany - December 14th, 2023

Generation of Longitudinal Panomics Data to improve the Disease understanding of Anca-Associated Vasculitis

Charité – Universitätsmedizin Berlin will collect Biosamples from Anca-Associated Vasculitis Patients

Evotec will Leverage its Unique…

Novozymes and Chr. Hansen have announced that the name of the future combined company will be ‘Novonesis’. Novonesis means ‘A new beginning’ and derives from the Greek word ‘genesis’. The name reflects a new era of biosolutions where innovation in…

Whether heart attack, stroke or other heart problems: Cardiovascular diseases are the most common cause of death in Germany. Even though mortality has fallen in recent years thanks to new examination and treatment methods, there is still a lot to be…

Infection with the stomach bacterium Helicobacter pylori could increase the risk of developing Alzheimer’s disease: In people over the age of 50, the risk following a symptomatic infection can be an average of 11 percent higher, and even more about…

Glycotope and Evotec enter licensing agreement to combine Glycotope antibodies and Evotec’s immune cell engager platform

New Asia-Pacific Hub Strengthens Singaporean MedTech Ecosystem

- Guaranteed portion of the transaction will extend cash runway past

regulatory milestones in Q1-2024

- The financial visibility will allow TME Pharma to file and receive

feedback from FDA on its IND and applications to expedited regulatory …

From 2024, the Federal Government and the State of Berlin will fund the establishment of the National Center for Tumor Diseases (NCT) Berlin. The new site is a cooperation between DKFZ and Charité, BIH, and Max Delbrück Center aimed at closely…